Emerald Advisers’s Celgene Corp CELG Stock Holding History

Emerald Advisers’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,395	Closed	-$203K	–	285
2017 Q3	$203K	Buy	+1,395	New	+$190K	0.01%	229
2014 Q3	–	Sell	-80	Closed	-$7K	–	456
2014 Q2	$7K	Buy	+80	New	+$6.08K	﹤0.01%	423

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Emerald Advisers's CELG Position: Q4 2017 in Review

Emerald Advisers sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,395 shares — an estimated $203K sold.

Emerald Advisers first reported a position in CELG in Q2 2014 and held it in 2 quarters. The position peaked at $203K in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

Emerald Advisers reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
Emerald Advisers sold 1,395 Celgene Corp shares in Q4 2017, an estimated $203K.
Emerald Advisers first reported a position in Celgene Corp in Q2 2014 and held it in 2 quarters.
Emerald Advisers's Celgene Corp position peaked at $203K in Q3 2017.
1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Emerald Advisers's 13F filing for Q4 2017, filed 5 Feb 2018.